Evidence map›Paper›PMID 41211759›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2026

Topical ruxolitinib ± oral baricitinib in the treatment of active non-segmental vitiligo: A retrospective analysis.

Yaohua Zhang, Tingting Zhu, Xianfa Tang, Weiran Li, He Huang, Yujun Sheng, Min Li, Yong Cui, Xuejun Zhang, Leihong Xiang and 1 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yaohua ZhangWorldwide Medical Center, Huashan Hospital, Fudan University, Shanghai, China.ORCID https://orcid.org/0000-0002-8737-2012
Tingting ZhuDepartment of Dermatology of First Affiliated Hospital, and Institute of Dermatology, Anhui Medical University, Hefei, Anhui, China.ORCID https://orcid.org/0009-0006-9386-1660
Xianfa TangDepartment of Dermatology of First Affiliated Hospital, and Institute of Dermatology, Anhui Medical University, Hefei, Anhui, China.
Weiran LiDepartment of Dermatology of First Affiliated Hospital, and Institute of Dermatology, Anhui Medical University, Hefei, Anhui, China.
He HuangDepartment of Dermatology of First Affiliated Hospital, and Institute of Dermatology, Anhui Medical University, Hefei, Anhui, China.
Yujun ShengDepartment of Dermatology, China-Japan Friendship Hospital, Beijing, China.
Min LiDepartment of Dermatology, The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital; Medical Center of Soochow University), Suzhou, Jiangsu, China.
Yong CuiDepartment of Dermatology, China-Japan Friendship Hospital, Beijing, China.ORCID https://orcid.org/0000-0002-6314-3610
Xuejun ZhangDepartment of Dermatology of First Affiliated Hospital, and Institute of Dermatology, Anhui Medical University, Hefei, Anhui, China.ORCID https://orcid.org/0000-0001-6881-9504
Leihong XiangDepartment of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.ORCID https://orcid.org/0000-0002-2712-3962
Bo ZhangDepartment of Dermatology, The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital; Medical Center of Soochow University), Suzhou, Jiangsu, China.ORCID https://orcid.org/0000-0002-5331-0323

Funding

Open Fund Project of Key Lab of Dermatology, Ministry of Education AYFYS2024-5
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

baricitinibefficacyJanus kinase inhibitorretrospective studyruxolitinibvitiligo

Identifiers

PMID41211759
PMCPMC13425705

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.